Subclinical Hyperthyroidism: Possible Danger of Overzealous Thyroxine Replacement Therapy
- 1 December 1988
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 63 (12) , 1223-1229
- https://doi.org/10.1016/s0025-6196(12)65409-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Reevaluation of L-Thyroxine DosageAnnals of Internal Medicine, 1986
- Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement?BMJ, 1986
- L-Thyroxine Dosage: A Reevaluation of Therapy with Contemporary PreparationsAnnals of Internal Medicine, 1986
- Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.BMJ, 1985
- Thyroxine replacement treatment: clinical judgment or biochemical control?BMJ, 1985
- ‘CHEMICAL HYPERTHYROIDISM’: THE SIGNIFICANCE OF ELEVATED SERUM THYROXINE LEVELS IN l‐THYROXINE TREATED INDIVIDUALSClinical Endocrinology, 1985
- Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.BMJ, 1984
- THE EFFECT OF MINOR INCREMENTS IN PLASMA THYROXINE ON HEART RATE AND URINARY SODIUM EXCRETIONClinical Endocrinology, 1983
- Elevated serum thyroxine concentration in patients receiving “replacement” doses of levothyroxineJournal of Endocrinological Investigation, 1982
- 'Chemical Hyperthyroidism'Archives of internal medicine (1960), 1982